In many ways, things are probably going a lot faster than many of us realise in the digital age as blogging and RSS aggregation gives way to lifestreaming and real time information...
Sent from my iPhone
« The complexity of cell signalling pathways in oncology | Main | Pfizer discontinues Sutent in colorectal cancer »
July 01, 2009
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8342ae08153ef011570a5c342970c
Listed below are links to weblogs that reference The Cluetrain Manifesto ten years on:
Comments
Publisher
- This blog is published by:
Sally Church, PhD
of Icarus Consultants, Inc.
The contents of this blog are the intellectual property of the author and all rights are reserved. No commercial use, copying or distribution is permitted without the author's express permission.
What we do
Icarus Consultants is a management consulting company focusing on marketing strategy and new product development to the Pharma and Biotech industry. We focus on specialist areas such as oncology, hematology, immunology, respiratory and HIV.
Our particular areas of interest include social media monitoring, key opinion leader research, competitive intelligence and landscape opportunity assessments. We use primary qualitative market research and buzz metrics to support our strategic analyses.
Company Web Site
Follow Me
FDA Pharma Hearing
Recent Comments
- roxanne on What can we learn from the Oscars?
- MaverickNY on Roche's ocrelizumab and AstraZeneca's cediranib bite the dust
- MaverickNY on What price end of life cancer care?
- Betsy Raymond Stevenson on What price end of life cancer care?
- twitter.com/mikehartCXO on Why do some Pharma companies do well in oncology and other's don't?
- MaverickNY on Why do some Pharma companies do well in oncology and other's don't?
- SBE on Why do some Pharma companies do well in oncology and other's don't?
- Tim Turnham on Update on malignant melanoma therapies
- Chris Iafolla on Making things happen in Pharma land
- MaverickNY on Making things happen in Pharma land
